Filing Flows › Vycor Medical (VYCO) › Q2 2025
Vycor Medical (VYCO) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 8, 2025
Vycor Medical (VYCO) reported revenue of $496K for the second quarter 2025 (Q2 2025), +22% from a year earlier and +14% from the quarter before. Operating margin was 10.3%, net earnings $24K (4.8% of revenue).
Vycor Medical, Q2 2025: revenue $496K (+22% year over year), operating margin 10.3%, net earnings $24K, operating cash flow $47K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $496K | +14% | +22% |
| Gross profit | $415K | +16% | +12% |
| Operating profit | $51K | — | +216% |
| Net earnings | $24K | — | — |
| Operating cash flow | $47K | — | -46% |
What changed
Revenue was $496K in Q2 2025, up 22% year over year and up 14% from the previous quarter. Vycor Medical Inc was the largest line at 97% of revenue. Vycor Medical Inc added $95K year over year (up 24%), 105% of the total change. Nova Vision Inc declined 23%.
Gross margin was 83.7%, down 7.7 points from a year earlier. Operating profit was $51K, a 10.3% margin (up 6.3 points year over year). Of the extra revenue versus a year earlier, 39% reached operating profit, above the 4% margin then. Operating expenses grew 3% against revenue growth of 22%. The fastest-growing cost line was Research & development (+86%). Net earnings were $24K. The effective tax rate was 7.1%.
Operating cash flow was $47K (down 46% year over year), 195% of net earnings. Non-cash charges added back $15K of depreciation and amortization and $18K of share-based compensation. Working capital and other items used $10K.
Questions
What was Vycor Medical's revenue in the second quarter 2025?
Vycor Medical (VYCO) reported revenue of $496K for the second quarter 2025 (Q2 2025), +22% from a year earlier and +14% from the quarter before.
Was Vycor Medical profitable in the second quarter 2025?
Operating profit was $51K (10.3% of revenue) and net earnings $24K.
Source: Vycor Medical 10-Q on SEC EDGAR.